KMG Fiduciary Partners LLC Has $10.05 Million Stake in Oracle Co. (NYSE:ORCL)

KMG Fiduciary Partners LLC decreased its holdings in shares of Oracle Co. (NYSE:ORCL - Free Report) by 10.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 71,908 shares of the enterprise software provider's stock after selling 8,495 shares during the quarter. Oracle accounts for approximately 0.8% of KMG Fiduciary Partners LLC's investment portfolio, making the stock its 29th largest position. KMG Fiduciary Partners LLC's holdings in Oracle were worth $10,053,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Norges Bank acquired a new position in shares of Oracle in the fourth quarter valued at approximately $2,216,314,000. Raymond James Financial Inc. acquired a new position in shares of Oracle in the fourth quarter valued at approximately $930,095,000. GAMMA Investing LLC increased its stake in shares of Oracle by 15,012.3% in the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of Oracle by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after buying an additional 2,296,069 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.

Analyst Ratings Changes

ORCL has been the subject of several recent research reports. Stifel Nicolaus lowered their price objective on Oracle from $175.00 to $150.00 and set a "hold" rating for the company in a research note on Tuesday, March 11th. Westpark Capital assumed coverage on Oracle in a report on Tuesday, April 1st. They issued a "buy" rating and a $195.00 target price on the stock. UBS Group reiterated a "market perform" rating on shares of Oracle in a report on Tuesday, March 11th. Bank of America reduced their target price on Oracle from $195.00 to $175.00 and set a "neutral" rating on the stock in a report on Tuesday, March 11th. Finally, DA Davidson reduced their target price on Oracle from $150.00 to $140.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $174.42.

Insider Transactions at Oracle

In related news, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction on Friday, April 11th. The stock was sold at an average price of $129.77, for a total value of $648,850.00. Following the completion of the sale, the director now directly owns 58,090 shares of the company's stock, valued at approximately $7,538,339.30. This represents a 7.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Naomi O. Seligman sold 2,866 shares of the stock in a transaction on Monday, May 5th. The shares were sold at an average price of $149.53, for a total value of $428,552.98. Following the completion of the sale, the director now directly owns 31,764 shares of the company's stock, valued at $4,749,670.92. The trade was a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,366 shares of company stock valued at $4,015,723 over the last ninety days. 42.20% of the stock is owned by company insiders.

Oracle Price Performance

Shares of NYSE:ORCL opened at $174.22 on Friday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. Oracle Co. has a twelve month low of $118.86 and a twelve month high of $198.31. The stock's 50 day moving average is $147.20 and its 200-day moving average is $160.46. The firm has a market capitalization of $487.29 billion, a price-to-earnings ratio of 42.60, a PEG ratio of 3.46 and a beta of 1.32.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The firm had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. During the same period in the previous year, the company earned $1.41 earnings per share. Oracle's revenue for the quarter was up 6.4% compared to the same quarter last year. Sell-side analysts forecast that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Thursday, April 10th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.15%. This is a positive change from Oracle's previous quarterly dividend of $0.40. The ex-dividend date was Thursday, April 10th. Oracle's dividend payout ratio is presently 46.95%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.